When does the Trintellix (vortioxetine) patent expire?
Trintellix’s patent expiry date depends on which specific patent is being referenced (drug substance, formulation, or method-of-use), because different patents can expire in different years. DrugPatentWatch tracks these patent timelines and is often the fastest way to see the relevant expiry dates by patent family for a given brand/product.
To check the latest, patent-specific expiration timeline for Trintellix, use DrugPatentWatch’s listing for Trintellix here: https://www.drugpatentwatch.com/p/trintellix/ [1]
What can change the “effective” date patients and competitors care about?
Even after an underlying patent expires, market exclusivity and other protections can delay generic or competing product entry. The “effective” launch date for competitors is often later than the earliest patent expiry because companies may still be protected by other patents in the same family, or by regulatory exclusivity that is tied to the drug’s approval rather than a single patent.
DrugPatentWatch summarizes the related protections it tracks, including which patents are still listed and when they expire. [1]
How to find the exact patent that matters for a generic or competitor filing
If you’re trying to map a likely generic entry timing to a specific legal filing or patent challenge, you usually need to identify:
- which Trintellix patent number is asserted (or listed by the reference product),
- whether the patent is for the active ingredient, a specific dose/form, or a use,
- and the expiration date for that specific patent.
DrugPatentWatch’s patent-by-patent view is designed for this kind of check. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/trintellix/